Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,931 | -75,736 | -34,625 | -20,689 | -9,791 |
| Depreciation Amortization | 1,753 | 127 | 216 | 159 | 105 |
| Income taxes - deferred | N/A | 65 | 76 | N/A | N/A |
| Accounts receivable | -1,601 | -29 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 6,546 | 1,577 | 2,842 | -313 | 312 |
| Other Working Capital | 4,152 | 2,012 | 1,493 | 919 | 216 |
| Other Operating Activity | 31,826 | 62,177 | 12,409 | 10,482 | 2,371 |
| Operating Cash Flow | $-21,255 | $-9,806 | $-17,589 | $-9,442 | $-6,787 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,047 | -1,065 | -1,145 | -6,643 | -1,300 |
| PPE Investments | -424 | -166 | -117 | -22 | -10 |
| Net Acquisitions | -29,150 | -29,150 | N/A | N/A | N/A |
| Purchase Of Investment | -400 | N/A | N/A | N/A | N/A |
| Sale Of Investment | -848 | -671 | 1,329 | N/A | N/A |
| Purchase Sale Intangibles | -3,301 | -61 | -5,433 | -6 | -6 |
| Other Investing Activity | -3,301 | -61 | -5,473 | -6 | -6 |
| Investing Cash Flow | $-37,170 | $-31,113 | $-5,406 | $-6,670 | $-1,315 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 80,676 | N/A | N/A | N/A | N/A |
| Debt Repayment | -31,283 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 45,172 | 44,039 | 30,937 | 31,356 | 9,276 |
| Common Stock Repurchased | -2,257 | -2,257 | -958 | 0 | N/A |
| Other Financing Activity | 0 | -3,165 | -998 | -1,844 | -898 |
| Financing Cash Flow | $92,308 | $38,617 | $28,981 | $29,511 | $8,378 |
| Beginning Cash Position | 5,997 | 5,997 | 11 | 11 | 11 |
| End Cash Position | 39,880 | 3,696 | 5,997 | 13,410 | 287 |
| Net Cash Flow | $33,883 | $-2,302 | $5,986 | $13,398 | $275 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,255 | -9,806 | -17,589 | -9,442 | -6,787 |
| Capital Expenditure | -424 | -166 | -117 | -22 | -10 |
| Free Cash Flow | -21,679 | -9,972 | -17,706 | -9,465 | -6,797 |